The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review

INTRODUCTION: This study aimed at evaluating the overall survival (OS) gain associated with human epidermal growth factor receptor 2 (HER2)-directed therapies in patients with metastatic breast cancer (mBC). METHODS: A bibliographic search was conducted in PubMed and Cochrane databases. Only phase I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Mendes, Diogo, Alves, Carlos, Afonso, Noémia, Cardoso, Fátima, Passos-Coelho, José Luís, Costa, Luís, Andrade, Sofia, Batel-Marques, Francisco
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4650834/
https://ncbi.nlm.nih.gov/pubmed/26578067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0648-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados